New Hopes for Plasma-Based Cancer Treatment

New Hopes and Challenges for Treatment of Neurodegenerative Disorders: Great Opportunities for Young Neuroscientists

New Hopes for Treatment of Alzheimer’s Disease

Alzheimer’s Disease (AD), the leading cause of dementia worldwide, is an irreversible progressive neurodegenerative disorder characterized by cognitive impairment and functional disability . Devastating nature of AD leads to serious social and economic impacts on the healthcare systems which implies the necessity of its proper management. It has been demonstrated that patients’ quality of life ...

Pancreatic cancer: New hopes after first line treatment

Pancreatic cancer is the fourth leading cause of cancer-related death worldwide. Extensive research has yielded advances in first-line treatment strategies, but there is no standardized second-line therapy. In this review, we examine the literature trying to establish a possible therapeutic algorithm.

MicroRNA in cancer: New hopes for antineoplastic chemotherapy

MicroRNAs (miRNAs) are a class of endogenous non-coding small RNAs that are evolutionarily conserved and widely distributed among species. Their major function is to negatively regulate mRNA target genes, and miRNA expression has been found to be deregulated in all human cancers, where miRNAs play critical roles in tumorigenesis, functioning either as tumor suppressors or as oncogenes. This rev...

New hopes for neurologically disabled.

The later half of the twentieth century witnessed rapid advances in our understanding of the nervous system, in health and disease, as a result of developments in diverse fields. Beginning in the 1950’s, neurochemical and neuropharmacological investigations resulted in the identification of a host of neurotransmitters, neuromodulators, neurohormones, the mechanisms of their storage, release, re...